144 related articles for article (PubMed ID: 7107076)
1. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
Jounela AJ; Pentikäinen PJ; Oksanen K
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
[TBL] [Abstract][Full Text] [Related]
2. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide pharmacokinetics in patients with acute myocardial infarction.
Pentikäinen PJ; Huikuri H; Jounela AJ; Wilen G
Eur J Clin Pharmacol; 1985; 28(1):45-51. PubMed ID: 3987785
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
Pentikäinen PJ; Halinen MO; Helin MJ
J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
[TBL] [Abstract][Full Text] [Related]
5. Disopyramide pharmacokinetics during recovery from myocardial infarction.
Bryson SM; Cairns CJ; Whiting B
Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
Aitio ML; Allonen H; Kanto J; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
[TBL] [Abstract][Full Text] [Related]
7. Disopyramide kinetics in patients with acute myocardial infarction.
Ilett KF; Madsen BW; Woods JD
Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
[TBL] [Abstract][Full Text] [Related]
8. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
10. Disopyramide in acute myocardial infarction: problems with changing pharmacokinetics.
Elliott HL; Thomson AH; Bryson SM
Eur J Clin Pharmacol; 1986; 30(3):345-7. PubMed ID: 3732373
[TBL] [Abstract][Full Text] [Related]
11. Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.
Graffner C; Lagerström PO; Lundborg PN; Rönn OF
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):414-9. PubMed ID: 7298249
[TBL] [Abstract][Full Text] [Related]
12. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
Taylor EH; Pappas AA
Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of disopyramide in patients with chronic renal failure.
Francois B; Mallein R; Rondelet J; Lussignol M
Eur J Drug Metab Pharmacokinet; 1983; 8(1):85-92. PubMed ID: 6861798
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.
Johnston A; Henry JA; Warrington SJ; Hamer NA
Br J Clin Pharmacol; 1980 Sep; 10(3):245-8. PubMed ID: 7437241
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of disopyramide.
Siddoway LA; Woosley RL
Clin Pharmacokinet; 1986; 11(3):214-22. PubMed ID: 3524956
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
Lima JJ; Boudoulas H; Blanford M
J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
[TBL] [Abstract][Full Text] [Related]
17. Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis.
Sevka MJ; Matthews SJ; Nightingale CH; Izard MW; Fieldman A; Chow MS
Clin Pharmacol Ther; 1981 Mar; 29(3):322-6. PubMed ID: 7471602
[TBL] [Abstract][Full Text] [Related]
18. Disopyramide phosphate: tissue uptake and relationship between drug concentrations in the plasma and myocardium of rats.
Karim A; Kook C; Campion J; Doherty M
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):222-36. PubMed ID: 921413
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of disopyramide after intravenous infusion to patients with myocardial infarction and heart failure.
Bonde J; Angelo HR; Bødtker S; Svendsen TL; Kampmann JP
Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):278-82. PubMed ID: 4024955
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]